WHO ICTRP trial

Single-arm, single-center, exploratory clinical trial of AK112 combined with…

ChiCTR2500098601 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500098601
Public title Single-arm, single-center, exploratory clinical trial of AK112 combined with mFOLFOX6 chemotherapy for neoadjuvant treatment of locally advanced rectal adenocarcinoma
Scientific title Single-arm, single-center, exploratory clinical trial of AK112 combined with mFOLFOX6 chemotherapy for neoadjuvant treatment of locally advanced rectal adenocarcinoma
Primary sponsor Affiliated Hospital of North Sichuan Medical College
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions locally advanced rectal adenocarcinoma
Interventions Test group:Treatment regimen: AK112 combined with mFOLFOX6. Patients with locally advanced rectal cancer were treated with AK112 combined with mFOLFOX6 neoadjuvant therapy for 4 cycles. Imaging evaluation was performed 2 weeks (+/-7 days)…
Registration date Mar 11, 2025
Target size Test group:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations